Inclisirán as an alternative treatment for Hypercholesterolemia

Autor: Jorge Andrés Ojeda Villota, Javier Alfredo Pérez Martínez, Luis Alberto Burgos de Moya, Rodrigo Alfonso Chavez Vega, Roxana Rivera Valencia, Laura Melissa Medina Medina, María Paula González Rodríguez, Ingrith Tatiana Poveda Castillo
Rok vydání: 2021
Předmět:
Zdroj: World Journal of Advanced Research and Reviews. 12:517-521
ISSN: 2581-9615
DOI: 10.30574/wjarr.2021.12.3.0694
Popis: Hypercholesterolemia (CH) is defined as the elevation of serum cholesterol levels, especially low-density lipoprotein (LDL) cholesterol, which is considered to be one of the most relevant risk factors for triggering cardiovascular disease, for This is vitally important to start treatment, there are several highly useful pharmacological groups for lipid-lowering therapy, among them we highlight the PCSK9 inhibitors, among the molecules that are part of this group we find inclisirán, this being a structure that promises a lot in regarding the management of hypercholesterolemia.
Databáze: OpenAIRE